1. Qasim, Hanan, Rajaei, Mehrdad, Xu, Ying, Wehrens, Xander H T, McConnell, Bradley K. 2024. AKAP12 Upregulation Associates With PDE8A to Accelerate Cardiac Dysfunction. In Circulation research, 134, 1006-1022. doi:10.1161/CIRCRESAHA.123.323655. https://pubmed.ncbi.nlm.nih.gov/38506047/
2. Fonseca-Camarillo, Gabriela, Furuzawa-Carballeda, Janette, Priego-Ranero, Ángel Alexis, Martínez-Benítez, Braulio, Yamamoto-Furusho, Jesús K. 2021. AKAP12/Gravin is over-expressed in patients with ulcerative colitis. In Immunologic research, 69, 429-435. doi:10.1007/s12026-021-09214-3. https://pubmed.ncbi.nlm.nih.gov/34327631/
3. Wu, Xuan, Luo, Yuhong, Wang, Shan, Chen, Lei, Liu, Weiwei. 2022. AKAP12 ameliorates liver injury via targeting PI3K/AKT/PCSK6 pathway. In Redox biology, 53, 102328. doi:10.1016/j.redox.2022.102328. https://pubmed.ncbi.nlm.nih.gov/35576690/
4. Flotho, Christian, Paulun, Annika, Batz, Christiane, Niemeyer, Charlotte M. . AKAP12, a gene with tumour suppressor properties, is a target of promoter DNA methylation in childhood myeloid malignancies. In British journal of haematology, 138, 644-50. doi:. https://pubmed.ncbi.nlm.nih.gov/17686059/
5. Yildirim, M, Suren, D, Yildiz, M, Bulbuller, N, Sezer, C. . AKAP12/Gravin gene expression in colorectal cancer: clinical importance and review of the literature. In Journal of B.U.ON. : official journal of the Balkan Union of Oncology, 18, 635-40. doi:. https://pubmed.ncbi.nlm.nih.gov/24065476/
6. Liu, Zhenkun, Hu, Siyuan, Zhao, Xinlei, Weng, Jialei, Du, Yabing. 2024. AKAP12 positive fibroblast determines immunosuppressive contexture and immunotherapy response in patients with TNBC by promoting macrophage M2 polarization. In Journal for immunotherapy of cancer, 12, . doi:10.1136/jitc-2024-009877. https://pubmed.ncbi.nlm.nih.gov/39448199/
7. Li, Ke, Wu, Xuan, Li, Yuan, Gonzalez, Frank J, Liu, Weiwei. 2023. AKAP12 promotes cancer stem cell-like phenotypes and activates STAT3 in colorectal cancer. In Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 25, 3263-3276. doi:10.1007/s12094-023-03230-5. https://pubmed.ncbi.nlm.nih.gov/37326825/